30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

Orthofix Posts 2Q16 Revenue -

Orthofix (OFIX) posted 2Q16 revenue of US $104.1MM, +3.1% from 2Q15, as-reported, with segment sales and growth on an as-reported basis, as follows:

  • Trauma $26.8MM, +4.8%
  • Spine $18.2MM, -5.9%
  • Orthobiologics $14.3MM, -6.7%
  • Other $44.8MM, +10.0% (BioStim)


This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.